Sign Up Today and Learn More About Candesant Biomedical Stock
Invest in or calculate the value of your shares in Candesant Biomedical or other pre-IPO companies through EquityZen's platform.
Candesant Biomedical Stock (CANB)
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.
About Candesant Biomedical Stock
Founded
2016
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Candesant Biomedical Press Mentions
Stay in the know about the latest news on Candesant Biomedical
Candesant Biomedical moves HQ from San Francisco, announces $35 million Series B round
bizjournals • Jun 08, 2023
Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™
biospace • Jun 06, 2023
Candesant Biomedical Management
Leadership team at Candesant Biomedical
President and CEO
Niquette Hunt
VP Product Development
Jesse Rosen
Join now and verify your accreditation status to gain access to:
- Candesant Biomedical current valuation
- Candesant Biomedical stock price
- Available deals in Candesant Biomedical and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Candesant Biomedical stock?
Accredited investors can buy pre-IPO stock in companies like Candesant Biomedical through EquityZen funds. These investments are made available by existing Candesant Biomedical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Candesant Biomedical stock?
Shareholders can sell their Candesant Biomedical stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."